TNFα-IP 8L1 Activators
TNFα-IP 8L1 Activators comprise a suite of chemical compounds that indirectly enhance the functional activity of TNFα-IP 8L1 through distinct and specific signaling pathways. Compounds such as Forskolin and Sphingosine-1-phosphate elevate secondary messengers like cAMP and modulate G-protein-coupled receptor (GPCR) signaling, respectively, thereby enhancing TNFα-IP 8L1's role in apoptosis and inflammation. Curcumin and Resveratrol exert their effects by modulating NF-κB and SIRT1 pathways, potentiallyreducing suppression and promoting the autophagic processes that TNFα-IP 8L1 is associated with. Kinase inhibitors, including Epigallocatechin gallate and Staurosporine, lift negative regulation within cell survival and inflammatory response pathways, facilitating the augmentation of TNFα-IP 8L1's activity.
Intracellular calcium and MAPK signaling modulators like Thapsigargin also play significant roles in enhancing TNFα-IP 8L1 activity. Thapsigargin's SERCA inhibition leads to increased intracellular calcium, activating calcium-dependent pathways crucial for TNFα-IP 8L1's function in cell signaling. Anisomycin's induction of stress-activated protein kinases represents another mechanism by which TNFα-IP 8L1 activity can be enhanced, as it places TNFα-IP 8L1 within a broader context of cellular stress response.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased levels of cyclic AMP (cAMP) within cells. Elevated cAMP levels can enhance TNFα-IP 8L1 activity by promoting PKA activation, which may phosphorylate proteins in pathways where TNFα-IP 8L1 is a critical player. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin has been shown to inhibit NF-κB activation, which may lead to the indirect enhancement of TNFα-IP 8L1 due to its role in inflammation regulation and potentially relieving suppression of pathways TNFα-IP 8L1 is involved in. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates the SIRT1 pathway, which is implicated in cellular stress responses. SIRT1 activation can enhance TNFα-IP 8L1 activity by modulating the autophagic process where TNFα-IP 8L1 might be involved. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate acts through G-protein-coupled receptors to influence cellular survival pathways, potentially enhancing TNFα-IP 8L1 activity by promoting survival signals where TNFα-IP 8L1 may play a role in apoptosis regulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate, a kinase inhibitor, may enhance TNFα-IP 8L1 by reducing negative regulation within the pathways where TNFα-IP 8L1 contributes to cell survival and inflammatory response modulation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin elevates intracellular calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). This increase in calcium can enhance TNFα-IP 8L1 activity by activating calcium-dependent signaling pathways associated with TNFα-IP 8L1. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, may selectively enhance TNFα-IP 8L1 activity by inhibiting kinases that negatively regulate pathways in which TNFα-IP 8L1 is involved. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that activates stress-activated protein kinases. This activation can enhance the functional activity of TNFα-IP 8L1 within cellular stress response pathways. | ||||||